Bespak maintains improved performance:
This article was originally published in Clinica
Executive Summary
Strong demand for its asthma inhaler valves drove first-half sales and profit increases at Bespak, the UK-based drug delivery device manufacturer. Sales rose by 10.4% to £39.4 million ($67 million) in the six months to November 1st, 1996. Pre-tax profit for the half year was 42.9% ahead of year-earlier figures, at £5 million. Bespak, which returned to profitability in fiscal 1996, is forecasting continued progress through the second half-year. The company expects further growth in UK sales of drug delivery devices, and anticipates improved profitability for its US operations.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.